Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 50 of 385 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/30/23
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 09/01/19
End: 01/01/22
Due: 01/01/23
Phase: N/A
Priority: Normal
Start: 07/31/22
End: 04/30/23
Due: 04/30/24
Phase: N/A
Priority: Normal
Start: 08/01/23
End: 07/27/24
Due: 07/27/25
Phase: N/A
Priority: Normal
Start: 09/27/22
End: 09/27/30
Due: 09/27/31
Phase: N/A
Priority: Normal
Start: 10/31/13
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 01/31/10
End: 01/31/15
Due: 01/31/16
Phase: N/A
Priority: Normal
Start: 10/01/21
End: 06/01/23
Due: 06/01/24
Phase: N/A
Priority: Normal
Start: 06/21/18
End: 07/30/20
Due: 07/30/21
Phase: N/A
Priority: Normal
Start: 02/01/23
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 05/01/19
End: 04/30/22
Due: 04/30/23
Phase: N/A
Priority: Normal
Start: 05/31/23
End: 04/30/25
Due: 04/30/26
Phase: N/A
Priority: Normal
Start: 01/01/23
End: 12/31/30
Due: 12/31/31
Phase: N/A
Priority: Normal
Start: 10/18/22
End: 12/30/24
Due: 12/30/25
Phase: N/A
Priority: Normal
Start: 03/23/11
End: 12/06/21
Due: 12/06/22
GEMOX-HAIC Plus GEM-SYS in Combination With Lenvatinib and PD-1 Inhibitor for Large Unresectable ICC
Phase: N/A
Priority: Normal
Start: 07/10/24
End: 07/10/25
Due: 07/10/26
Phase: N/A
Priority: Normal
Start: 12/01/24
End: 03/31/25
Due: 03/31/26
Phase: N/A
Priority: Normal
Start: 11/01/23
End: 12/31/31
Due: 12/31/32
Phase: N/A
Priority: Normal
Start: 07/06/22
End: 01/01/24
Due: 01/01/25
Phase: N/A
Priority: Normal
Start: 08/01/20
End: 09/30/23
Due: 09/30/24
Phase: N/A
Priority: Normal
Start: 11/23/23
End: 08/30/24
Due: 08/30/25
Phase: N/A
Priority: Normal
Start: 07/01/17
End: 07/31/21
Due: 07/31/22
Phase: N/A
Priority: Normal
Start: 10/01/21
End: 11/30/23
Due: 11/30/24
Phase: N/A
Priority: Normal
Start: 04/17/23
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 01/01/24
End: 12/31/25
Due: 12/31/26